Key result
Normotensive primary aldosteronism presents with severe hypokalemia and life-threatening ventricular arrhythmias.
Why the study?
Primary aldosteronism can present without hypertension or hypokalemia, and atypical presentations such as life-threatening ventricular arrhythmias without classic features pose a significant diagnostic challenge.
Case Report (n=1)
No
Highlights the critical need for aldosterone-to-renin ratio (ARR) screening in patients with unexplained hypokalemia and ventricular arrhythmias, even in the absence of hypertension.
Answers are grounded in this paper and cite their sources.
Normotensive primary aldosteronism may precipitate arrest via hypokalemia; this case leaves open whether ARR screening is warranted in unexplained arrhythmias.
Primary aldosteronism (PA), the most common cause of secondary hypertension, is characterized by autonomous adrenal aldosterone overproduction independent of the renin-angiotensin system, resulting in sodium retention, potassium wasting, and cardiovascular sequelae that exceed the risk attributable to blood pressure elevation alone. Although hypertension is the predominant clinical manifestation, PA may also present without hypertension or hypokalemia, making atypical presentations a significant diagnostic challenge. Aldosterone-mediated myocardial fibrosis combined with hypokalemia-driven electrophysiologic instability can precipitate life-threatening ventricular arrhythmias that may constitute the dominant clinical presentation in the absence of classic features. We present a case of normotensive PA in which diagnostic delay resulted in recurrent ventricular arrhythmias and sudden cardiac arrest before identification of the underlying etiology, underscoring the importance of aldosterone-to-renin ratio (ARR) screening in patients with unexplained treatment-resistant hypokalemia and arrhythmia regardless of blood pressure status. Early recognition and targeted treatment of PA in atypical presentations are essential to mitigate irreversible cardiovascular morbidity.
No takes yet. Share an insight, caveat, or question.
Daniel et al. (2026) conducted a case report in Normotensive Primary Aldosteronism (n=1). Spironolactone was evaluated. Normotensive primary aldosteronism presented atypically with severe treatment-resistant hypokalemia and life-threatening ventricular arrhythmias in a 42-year-old woman.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: